Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant

Early treatment of neonatal diabetes with sulfonylureas has been proven to produce marked improvements of neurodevelopment, beside the demonstrated efficacy on glycemic control. Several barriers still prevent an early treatment in preterm babies including the limited availability of suitable galenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Galderisi, Alfonso, Kermorvant‐Duchemin, Elsa, Daruich, Alejandra, Bonnard, Adeline Alice, Lapillonne, Alexandre, Aubelle, Marie‐Stéphanie, Perrella, Bruna, Vial, Yoann, Cave, Héléne, Berdugo, Marianne, Jarreau, Pierre‐Henri, Polak, Michel, Beltrand, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981413/
https://www.ncbi.nlm.nih.gov/pubmed/36873092
http://dx.doi.org/10.1002/jmd2.12358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981413/
https://www.ncbi.nlm.nih.gov/pubmed/36873092
http://dx.doi.org/10.1002/jmd2.12358

Ejemplares similares